Search for: "Sanofi-Aventis"
Results 1 - 20
of 563
Sorted by Relevance
|
Sort by Date
26 Dec 2010, 9:59 pm
The appeal arose from a dispute between Sun and Plaintiffs-Appellees Sanofi-Aventis, Sanofi-Aventis U.S. [read post]
30 Jun 2010, 3:50 am
Sanofi-Aventis, France's largest drugmaker, agreed to buy closely held TargeGen to add treatments for certain forms of leukemia and blood disorders, Bloomberg News reported. [read post]
2 Jul 2010, 4:30 am
Sanofi-Aventis, the French drug giant, is reportedly preparing for a U.S acquisition that could be worth $20 billion or more, Bloomberg News reported. [read post]
9 Nov 2011, 9:59 pm
By Donald Zuhn -- In an appeal decided last month, the Federal Circuit reversed a decision by the District Court for the Southern District of New York awarding prejudgment interest to Plaintiffs-Appellees Sanofi-Aventis, Sanofi-Synthelabo, Inc., and Bristol-Myers Squibb Sanofi Pharmaceuticals Holding Partnership ("Sanofi"); affirmed the District Court's denial of a motion for leave to file a supplemental answer, affirmative defenses, and… [read post]
2 Aug 2023, 11:05 am
The Federal Circuit reversed a Patent Trial and Appeal Board (“Board”) decision finding the challenged claims of Sanofi-Aventis’ ’614 patent unpatentable as obvious. [read post]
19 Feb 2008, 1:23 am
Pharmaceutical company Sanofi-Aventis filed a complaint in Los Angeles, California District Court seeking a declaratory judgment that three medical device patents are invalid and not infringed by Sanofi's syringes. [read post]
27 Jul 2010, 9:56 pm
Sanofi-Aventis, et al. v. [read post]
9 Feb 2007, 11:37 am
The suit relates to Sanofi-Aventis' blockbuster... [read post]
14 Nov 2013, 9:59 pm
By Donald Zuhn -- Last week, in Sanofi-Aventis v. [read post]
17 Oct 2008, 8:57 am
Devenish Nutrition Ltd v Sanofi-Aventis SA (France) and others [2008] EWCA Civ 1086; [2008] WLR (D) 317 “An account of profits could not be awarded on a claim for a non-proprietary tort. [read post]
7 Feb 2023, 12:00 pm
Sanofi Adventis v. [read post]
15 Apr 2009, 11:37 am
European pharmaceutical giant Sanofi-Aventis continued its buying spree by acquiring privately owned U.S. biopharmaceutical company BiPar Sciences on Wednesday. [read post]
4 Nov 2008, 9:39 am
Devenish Nutrition Ltd v Sanofi-Aventis SA (France) and Others Court of Appeal “An account of profits could not be awarded on a claim for a nonproprietary tort. [read post]
23 Jul 2010, 1:38 pm
Sanofi-Aventis has made an informal takeover approach to Genzyme, a person briefed on the matter told DealBook on Friday, as the French drug maker seeks to bolster its biotechnology offerings. [read post]
28 Oct 2010, 4:38 am
The chief executive of Sanofi-Aventis reiterated his belief that French company's $18.5 billion hostile bid for Genzyme represented good value for the U.S. biotechnology firm, saying: "Nothing in what Genzyme has said in recent weeks would cause us to change our offer. [read post]
1 Aug 2011, 8:41 am
Briefly, Sanofi-Aventis had an Australian patent on the compound, which expired in 2004. [read post]
31 May 2007, 9:31 pm
Singer -- In a May 29, 2007 press release, sanofi-aventis and UCB announced that the FDA approved Xyzal ® (active ingredient: levocetirizine dihydrochloride) a once-daily prescription antihistamine for the relief of seasonal and perennial allergic rhinitis, as well as for the treatment of chronic idiopathic urticaria (hives) in... [read post]
18 Jan 2015, 9:06 pm
Sanofi-Aventis U.S. [read post]
10 Sep 2009, 9:59 pm
The case, Sanofi-Aventis U.S. [read post]
13 Nov 2013, 8:40 pm
(“Pfizer”) […].Sanofi-Aventis at *2. [read post]
